<DOC>
	<DOCNO>NCT00457782</DOCNO>
	<brief_summary>The aim study determine safety , tolerability dose-limiting toxicity KW-2478 determine Maximum Tolerated Dose recommend Phase II dose patient relapsed/refractory MM , CLL B-cell NHL .</brief_summary>
	<brief_title>A Phase I Safety , PK PD Study KW-2478 Patients With Multiple Myeloma , Chronic Lymphocytic Leukaemia B-cell Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>This Phase I , open-label , dose-escalation study KW-2478 patient relapsed/refractory multiple myeloma , chronic lymphocytic leukaemia B-cell Non-Hodgkin 's lymphoma establish therapeutic alternative . Up 42 patient enrol six investigational site period approximately 12 month MTD reach . An additional 12 patient may enrol MTD expand cohort one eligible condition .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<criteria>1 . Patients confirm diagnosis Multiple Myeloma , Chronic Lymphocytic Leukaemia , Bcell NonHodgkin 's Lymphoma , least two prior standard treatment regimens without establish therapeutic alternative . 2 . Signed IECapproved inform consent 3 . ECOG performance status 0 , 1 2 ; 4 . Life expectancy least 3 month ; 5 . Adequate haematologic status , liver function renal function 6 . Patients reproductive potential must agree follow accepted birth control method study 1 . No anticancer treatment â‰¥ 3 week prior receive study drug 2 . Any severe , acute chronic illness 3 . No prior concurrent malignancy 4 . Immunosuppressant therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Blood disorder</keyword>
	<keyword>Leukaemia , Adult Chronic</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Multiple Myeloma</keyword>
</DOC>